Salivary gland mucoepidermoid carcinoma is a clinically, morphologically and genetically heterogeneous entity: a clinicopathological study of 40 cases with emphasis on grading, histological variants and presence of the t(11;19) translocation.
about
Prospective testing of mucoepidermoid carcinoma for the MAML2 translocation: clinical implicationsGenomic aberrations of MDM2, MDM4, FGFR1 and FGFR3 are associated with poor outcome in patients with salivary gland cancer.Morphological heterogeneity of oral salivary gland carcinomas: a clinicopathologic study of 41 cases with long term follow-up emphasizing the overlapping spectrum of adenoid cystic carcinoma and polymorphous low-grade adenocarcinoma.Loss of PTEN is associated with elevated EGFR and HER2 expression and worse prognosis in salivary gland cancerClear cell changes in salivary gland neoplasms: A 20-year retrospective study.Cytomegalovirus-induced salivary gland pathology: resistance to kinase inhibitors of the upregulated host cell EGFR/ERK pathway is associated with CMV-dependent stromal overexpression of IL-6 and fibronectinSalivary gland carcinomas.Recent advances in the diagnostic pathology of salivary carcinomas.Cytomegalovirus and Mucoepidermoid carcinoma: A possible causal relationship? A pilot study.Aberrations of MET are associated with copy number gain of EGFR and loss of PTEN and predict poor outcome in patients with salivary gland cancer.Predictors of cervical lymph node metastasis in salivary gland cancer.Histologic grade as prognostic indicator for mucoepidermoid carcinoma: a population-level analysis of 2400 patients.The many faces of acinic cell carcinomas of the salivary glands: a study of 40 cases relating histological and immunohistological subtypes to clinical parameters and prognosis.Mucoepidermoid Carcinoma of the Salivary Glands: Survival and Prognostic Factors.Silymarin and its active component silibinin act as novel therapeutic alternatives for salivary gland cancer by targeting the ERK1/2-Bim signaling cascade.
P2860
Q28271828-05CAC560-BFFE-45F1-8403-891B926CF155Q34504939-15458E4F-8302-4656-87CA-E1E297FED4DFQ34976407-2FCA9BB3-6D60-4182-AEB1-E9979679891BQ35764742-AA2F9D81-8A17-4ED3-B0FA-7B1C89C4C3B5Q36340760-C644F7EA-2045-451A-B919-619B1B19E2B1Q36698067-449C26E5-3DD1-44A1-BA0E-8ABBDC0C8AB6Q38030395-0F984BAD-ABA2-4808-89C7-247DB90CF518Q38244735-BA910F76-4715-44FE-8CDB-924F74BCBF94Q38717606-20B2F6F4-8AE2-4B54-8B99-59AF950FC423Q39503071-CD43DF85-BE22-4449-9FB7-7913E89BB97DQ43529428-CDA3BCA4-89C9-4EE5-9AEF-DA48A1F46952Q43692851-EC88AAD9-FC08-45A3-B119-4C9229A42A49Q43991953-4F5BEEB6-3DED-442C-BD70-EB07B6E66212Q47241572-EDB0F90C-B4DC-4A68-BBAA-DEAB14D539AFQ52098928-0B933BCD-BD04-4483-8458-783724F960E4
P2860
Salivary gland mucoepidermoid carcinoma is a clinically, morphologically and genetically heterogeneous entity: a clinicopathological study of 40 cases with emphasis on grading, histological variants and presence of the t(11;19) translocation.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Salivary gland mucoepidermoid ...... of the t(11;19) translocation.
@en
Salivary gland mucoepidermoid ...... of the t(11;19) translocation.
@nl
type
label
Salivary gland mucoepidermoid ...... of the t(11;19) translocation.
@en
Salivary gland mucoepidermoid ...... of the t(11;19) translocation.
@nl
prefLabel
Salivary gland mucoepidermoid ...... of the t(11;19) translocation.
@en
Salivary gland mucoepidermoid ...... of the t(11;19) translocation.
@nl
P2093
P2860
P1433
P1476
Salivary gland mucoepidermoid ...... of the t(11;19) translocation.
@en
P2093
Abbas Agaimy
Clemens Stiegler
Gero Brockhoff
Johannes Zenk
Maximilian Müller
Stephan Schwarz
Tobias Ettl
P2860
P304
P356
10.1111/J.1365-2559.2011.03777.X
P577
2011-03-03T00:00:00Z